← Back to Search

Other

Sucrose Cigarettes for Tobacco Use

N/A
Recruiting
Led By Irina Stepanov, PhD
Research Sponsored by Masonic Cancer Center, University of Minnesota
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Stable vitals sign measurements (systolic BP ≤ 160 and >90 mmHg, diastolic BP ≤ 100 and >50 mmHg and heart rate ≤105 and > 45 bpm) as determined by the licensed medical professional
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up end of intervention (2-3 weeks from enrollment)
Awards & highlights

Study Summary

This trial will study the dangers of smoking and how it affects DNA.

Who is the study for?
This trial is for adults over 21 who currently smoke cigarettes with medium sugar content. They must be in good physical and mental health, have stable vital signs, and not plan to quit smoking within the next month. Pregnant or nursing women, those planning pregnancy, or individuals with significant medical conditions affecting biomarker data cannot participate.Check my eligibility
What is being tested?
The study is examining how different levels of sugar in cigarettes affect smokers' appeal towards smoking, their intensity of smoking, and the potential risks such as DNA damage in the mouth from aldehydes and oxidative stress caused by sugars during smoking.See study design
What are the potential side effects?
While specific side effects are not listed for this trial since it involves regular cigarette use rather than a new medication or treatment, typical risks associated with tobacco use include respiratory issues, increased cancer risk, heart disease, stroke and other health problems.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
My blood pressure and heart rate are within a safe range.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~end of intervention (2-3 weeks from enrollment)
This trial's timeline: 3 weeks for screening, Varies for treatment, and end of intervention (2-3 weeks from enrollment) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
To evaluate the impact of sugar content on behavioral measures
To evaluate the impact of sugar content on smoking intensity
To evaluate the impact of sugar content on subjective responses to cigarettes (e.g., reinforcing and sensory effects)

Trial Design

1Treatment groups
Experimental Treatment
Group I: Impact of Sugar ContentExperimental Treatment1 Intervention
Participants will be ask to attend 4 laboratory sessions during which they will be asked to smoke their usual brand (UB) cigarettes and then one of three study cigarettes with low, medium and high levels of sugar in separate sessions using a within-subject design with conditions counterbalanced determined by a Latin square. In each session, smokers will be asked to smoke a cigarette in a standardized manner (10 puffs,30 second interval between puffs) and 1 hour later, ad libitum. Each of the sessions will be separated by at least 48 hours but not more than 5 days.

Find a Location

Who is running the clinical trial?

Masonic Cancer Center, University of MinnesotaLead Sponsor
274 Previous Clinical Trials
14,755 Total Patients Enrolled
5 Trials studying Tobacco Use
394 Patients Enrolled for Tobacco Use
Irina Stepanov, PhDPrincipal InvestigatorUniversity of Minnesota, Division of Environmental Health Sciences
2 Previous Clinical Trials
180 Total Patients Enrolled
Dorothy HatsukamiPrincipal InvestigatorMasonic Cancer Center Tobacco Research Programs

Media Library

Sucrose cigarettes (Other) Clinical Trial Eligibility Overview. Trial Name: NCT05308316 — N/A
Tobacco Use Research Study Groups: Impact of Sugar Content
Tobacco Use Clinical Trial 2023: Sucrose cigarettes Highlights & Side Effects. Trial Name: NCT05308316 — N/A
Sucrose cigarettes (Other) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05308316 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there still slots available for people to join this medical experiment?

"Indeed, this medical trial is actively enlisting participants. The original posting date for the study was on February 24th 2022 with the most up-to-date update having been done last March 25th."

Answered by AI

How many participants are being observed in this clinical trial?

"Affirmative. The information on clinicaltrials.gov points to this medical experiment actively recruiting candidates, with the initial post being dated February 24th 2022 and last updated March 25th 2022. There is a need for 36 participants at 1 centre."

Answered by AI
Recent research and studies
clinicaltrials.govStudy
Sugars in Cigarettes
2022. "Sugars in Cigarettes". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05308316.
~10 spots leftby May 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top